Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA™ (olezarsen) as an adjunct to diet to reduce triglycerides in adults ...
EASE-1 (NCT03690206) is a randomized, double-blind Phase 3 trial that enrolled a total of 106 SBS patients with intestinal failure who were dependent on parenteral support for at least three days per ...
If your giftee wants a complete surprise, try a blind box from the Two Blind Brothers. Choose a box from $38 to $198. Each box comes with a mystery assortment of clothing and accessories, and 100% of ...